Registration Dossier

Toxicological information


Currently viewing:

Administrative data

Description of key information

There are no carcinogenicity data for the substance. There was no evidence of mutagenicity in either in vitro or in vivo genotoxicity studies with the substance and there were no indications of a potential concern for carcinogenicity (for example pre-neoplastic and hyperplasic lesions) from repeated dose toxicity studies with the substance.

In addition, no structurally related analogues were identified for 2,2-bis(chloromethyl)trimethylene bis(bis(2-chloroethyl)phosphate) which would lead to a concern for carcinogenicity.

Key value for chemical safety assessment

Justification for classification or non-classification

Based on the available information the substance should not be classified for carcinogenicity in accordance with the criteria of

regulation (EC) 1272/2008 and EC Dir. 67/548 and adaptations.

Additional information